Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Highly Active Antiretroviral Therapy”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00267865
What this trial is testing

Chemotherapy and HAART to Treat AIDS-related Primary Brain Lymphoma

Who this might be right for
AIDS-Related-Primary Central Nervous System Lymphoma
National Cancer Institute (NCI) 12
Early research (Phase 1)WithdrawnNCT00157027
What this trial is testing

RHIV A Pilot Study Refractory or Intolerant to Highly Active Antiretroviral Therapy (HAART)

Who this might be right for
HIV Infections
Atlantic Health System
Testing effectiveness (Phase 2)Study completedNCT00642499
What this trial is testing

Dronabinol Versus Placebo in Treatment and Prevention of Highly Active Anti-Retroviral Therapy (HAART)-Related Nausea and Vomiting

Who this might be right for
Highly Active Antiretroviral Therapy (HAART)-Related Nausea and VomitingHIV Infections
Solvay Pharmaceuticals 103
Large-scale testing (Phase 3)Study completedNCT01227044
What this trial is testing

Reducing Heavy Drinking to Optimize HIV/AIDS Treatment and Prevention

Who this might be right for
Reduction in Heavy Drinking in Patients With HIV
Yale University 51
Post-approval studies (Phase 4)Ended earlyNCT00775606
What this trial is testing

Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease

Who this might be right for
Acquired Immune Deficiency Syndrome
Rush University Medical Center 15
Not applicableWithdrawnNCT00051090
What this trial is testing

Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIV

Who this might be right for
HIV InfectionsHepatitis B
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Study completedNCT00000870
What this trial is testing

A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 200
Early research (Phase 1)Study completedNCT00006066
What this trial is testing

Interleukin-2 Plus Anti-HIV Therapy in HIV-Infected Children With Weakened Immune Systems

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 92
Not applicableStudy completedNCT01038401
What this trial is testing

Residual Replication of HIV-1 in the Gut Associated Lymphoid Tissue (GALT) of Patients on Highly Active Antiretroviral Therapy (HAART): the ANRS EP 44 Study

Who this might be right for
HIV Infection
ANRS, Emerging Infectious Diseases 30
Not applicableStudy completedNCT00001117
What this trial is testing

Evaluate the Effects of Anti-HIV Drugs in HIV-Positive Patients Who Also Have Hepatitis C Infection

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 60
Post-approval studies (Phase 4)Study completedNCT00232908
What this trial is testing

QUALITE Study - A Study of Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With Human Immunodeficiency Virus-1 (HIV-1) Infection

Who this might be right for
HIV Infections
Hoffmann-La Roche 361
Post-approval studies (Phase 4)UnknownNCT00162643
What this trial is testing

PI Vs. NNRTI Based Therapy for HIV Advanced Disease

Who this might be right for
Acquired Immunodeficiency Syndrome
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 300
Not applicableStudy completedNCT00002392
What this trial is testing

Thalidomide in HIV-Infected Patients Who Are Receiving HAART

Who this might be right for
HIV Infections
Rockefeller University 12
Not applicableStudy completedNCT00001899
What this trial is testing

Immune and Viral Status of HIV-Infected Patients After Stopping Combination Antiretroviral Therapy

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 38
Testing effectiveness (Phase 2)Study completedNCT02527096
What this trial is testing

A Trial Evaluating Maintenance Therapy With Lamivudine (Epivir®) and Dolutegravir (Tivicay®) in Human Immunodeficiency Virus 1 (HIV-1) Infected Patients Virologically Suppressed With Triple Highly Active Antiretroviral Therapy (HAART) (ANRS 167 Lamidol)

Who this might be right for
HIV-1 Infection
ANRS, Emerging Infectious Diseases 110
Not applicableStudy completedNCT02713750
What this trial is testing

RH and Adolescents

Who this might be right for
Reproductive Health
The HIV Netherlands Australia Thailand Research Collaboration 77
Large-scale testing (Phase 3)WithdrawnNCT00089518
What this trial is testing

Optimal Treatment for Kidney Disease in HIV Infected Adults

Who this might be right for
HIV InfectionsKidney Disease
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Study completedNCT00076518
What this trial is testing

The Effect of Fish Oil Plus Fenofibrate on Triglyceride Levels in People Taking Highly Active Antiretroviral Therapy (HAART)

Who this might be right for
HIV InfectionsHypertriglyceridemia
National Institute of Allergy and Infectious Diseases (NIAID) 100
Large-scale testing (Phase 3)UnknownNCT00005002
What this trial is testing

Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)

Who this might be right for
HIV Infections
Agouron Pharmaceuticals 688
Testing effectiveness (Phase 2)Study completedNCT01403051
What this trial is testing

High Dose Vitamin D and Calcium for Bone Health in Individuals Initiating HAART

Who this might be right for
HIV-1 Infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 167
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation